SELLAS Life Sciences Group, Inc. 8-K

What Happened

• SELLAS Life Sciences Group, Inc. announced and furnished a press release on March 19, 2026 reporting its financial results for the year ended December 31, 2025 and providing a corporate update. The press release is included in the 8-K as Exhibit 99.1 and is incorporated by reference.

Key Details

• Press release date: March 19, 2026.
• Reporting period: year ended December 31, 2025 (results announced).
• Press release furnished as Exhibit 99.1 to the Form 8-K.
• Form 8-K was signed on March 19, 2026 by John T. Burns, Senior Vice President and Chief Financial Officer.

Why It Matters

• An Item 2.02 8-K signals the company has publicly disclosed updated earnings and financial condition information; investors should review the March 19 press release for revenue, net income/loss, cash position, guidance, and any operational developments.
• The filing provides the official disclosure channel for material financial results—if you follow SLS, check the press release and the company’s subsequent SEC filings (including the full annual report or 10-K when available) for detailed figures and management commentary.